Prognosis

What is the prognosis?

The prognosis of Left Ventricular Assist Devices (LVADs) varies by age, race, and gender.
Younger patients (≤50 years) have the best survival rates and are more likely to receive a heart transplant, while older patients (>70 years) face higher risks of stroke, infection, and mortality with LVAD therapy.
Black patients tend to have higher complication rates, including thromboembolism and infection, and face barriers to heart transplantation, whereas White patients generally experience better outcomes due to greater access to care.
Hispanic and Asian patients have similar survival rates when adjusted for socioeconomic factors.
Men are more likely to receive LVADs but face higher bleeding risks, while women, despite being underrepresented in studies, often have comparable or better survival rates but a greater risk of right heart failure.
Overall, 1-year survival with an LVAD is around 80–85%, with newer models improving long-term outcomes.

Studies indicate that there is a notable incidence of re-operations among LVAD patients.
Specifically, approximately 23.8% of patients have undergone a re-exchange within five years post-implantation
Device Failure: Mechanical or electrical failures can necessitate replacement procedures, with mechanical/electrical failure accounting for about 57% of re-operations
Haemolysis/Thrombosis: These complications can lead to pump dysfunction, resulting in a need for surgical intervention; they are noted as second leading causes for LVAD replacements.
Infections: Device-associated infections are also significant contributors to the decision to perform re-operations, cited at about 14% for replacement surgeries